maltotriose has been researched along with fludarabine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appelhans, D; Borowiec, M; Bryszewska, M; Franiak-Pietryga, I; Kowalczyk, P; Maciejewski, H; Misiewicz, M; Ostrowska, K; Voit, B | 1 |
| Appelhans, D; Borowiec, M; Bryszewska, M; Cebula-Obrzut, B; Franiak-Pietryga, I; Kaczmarek, A; Klajnert-Maculewicz, B; Maciejewski, H; Robak, T; Smolewski, P; Voit, B; Ziemba, B; Ziółkowska, E | 1 |
| Appelhans, D; Borowiec, M; Bryszewska, M; Danilewicz, M; Franiak-Pietryga, I; Jander, M; Kuncman, W; Sikorska, H; Ziemba, B | 1 |
| Appelhans, D; Borowiec, M; Bryszewska, M; Danilewicz, M; Franiak-Pietryga, I; Jander, M; Kuncman, W; Lewkowicz, P; Ostrowska, K; Sikorska, H; Ziemba, B | 1 |
4 other study(ies) available for maltotriose and fludarabine
| Article | Year |
|---|---|
Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway.
Topics: Antineoplastic Agents; B-Lymphocytes; Base Sequence; Cell Line, Tumor; Chromosomes, Human, Pair 17; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Microarray Analysis; Molecular Targeted Therapy; Nanoparticles; Neoplasm Proteins; Polypropylenes; Precision Medicine; Proto-Oncogene Proteins c-bcr; Sequence Deletion; Signal Transduction; Trisaccharides; Vidarabine | 2016 |
Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays.
Topics: Aged; Aged, 80 and over; Antimetabolites; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Dendrimers; Female; Gene Expression Regulation, Leukemic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Polypropylenes; Trisaccharides; Vidarabine | 2017 |
Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Marrow; Cell Line, Tumor; Dendrimers; Drug Development; Heterografts; Humans; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Neoplasms, Experimental; Polypropylenes; Tissue Distribution; Trisaccharides; Vidarabine | 2020 |
Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
Topics: Animals; Cell Line, Tumor; Dendrimers; Drug Delivery Systems; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Mice, Inbred NOD; Neoplasms, Experimental; Pilot Projects; Polypropylenes; Trisaccharides; Vidarabine | 2020 |